D.E. Shaw & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.94M | Sell |
|
|||||
|
2025
Q1 | $34.9M | Sell |
|
|||||
|
2024
Q4 | $107M | Buy |
|
|||||
|
2024
Q3 | $64.4M | Sell |
|
|||||
|
2024
Q2 | $79.7M | Sell |
|
|||||
|
2024
Q1 | $149M | Buy |
|
|||||
|
2023
Q4 | $86.7M | Sell |
|
|||||
|
2023
Q3 | $89.4M | Buy |
|
|||||
|
2023
Q2 | $88.6M | Buy |
|
|||||
|
2023
Q1 | $64.6M | Buy |
|
|||||
|
2022
Q4 | $31.9M | Sell |
|
|||||
|
2022
Q3 | $34.2M | Sell |
|
|||||
|
2022
Q2 | $78.5M | Sell |
|
|||||
|
2022
Q1 | $194M | Sell |
|
|||||
|
2021
Q4 | $224M | Sell |
|
|||||
|
2021
Q3 | $311M | Buy |
|
|||||
|
2021
Q2 | $157M | Buy |
|
|||||
|
2021
Q1 | $117M | Sell |
|
|||||
|
2020
Q4 | $207M | Buy |
|
|||||
|
2020
Q3 | $95.6M | Buy |
|
|||||
|
2020
Q2 | $42.9M | Sell |
|
|||||
|
2020
Q1 | $70.7M | Sell |
|
|||||
|
2019
Q4 | $81.9M | Sell |
|
|||||
|
2019
Q3 | $118M | Sell |
|
|||||
|
2019
Q2 | $160M | Sell |
|
|||||
|
2019
Q1 | $185M | Sell |
|
|||||
|
2018
Q4 | $194M | Sell |
|
|||||
|
2018
Q3 | $244M | Buy |
|
|||||
|
2018
Q2 | $187M | Buy |
|
|||||
|
2018
Q1 | $156M | Buy |
|
|||||
|
2017
Q4 | $62.9M | Buy |
|
|||||
|
2017
Q3 | $49.3M | Sell |
|
|||||
|
2017
Q2 | $104M | Buy |
|
|||||
|
2017
Q1 | $62.8M | Sell |
|
|||||
|
2016
Q4 | $47M | Buy |
|
|||||
|
2016
Q3 | $39.1M | Sell |
|
|||||
|
2016
Q2 | $84M | Sell |
|
|||||
|
2016
Q1 | $91.1M | Buy |
|
|||||
|
2015
Q4 | $83.4M | Buy |
|
|||||
|
2015
Q3 | $39.4M | Sell |
|
|||||
|
2015
Q2 | $98.8M | Sell |
|
|||||
|
2015
Q1 | $132M | Buy |
|
|||||
|
2014
Q4 | $120M | Buy |
|
|||||
|
2014
Q3 | $48.1M | Sell |
|
|||||
|
2014
Q2 | $87.5M | Sell |
|
|||||
|
2014
Q1 | $134M | Buy |
|
|||||
|
2013
Q4 | $53.7M | Buy |
|
|||||
|
2013
Q3 | $17.7M | Sell |
|
|||||
|
2013
Q2 | $24.4M | Buy |
|